These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 32145275)

  • 1. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    Lippi G; Plebani M
    Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.
    Heesom L; Rehnberg L; Nasim-Mohi M; Jackson AIR; Celinski M; Dushianthan A; Cook P; Rivinberg W; Saeed K
    J Glob Antimicrob Resist; 2020 Sep; 22():782-784. PubMed ID: 32717489
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.
    Rinaldi I; Muthalib A; Astowo P; Irawan B; Susanto N; Magdalena L; Maha IHRT; Wicaksono S
    Acta Med Indones; 2020 Apr; 52(2):163-171. PubMed ID: 32778631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
    Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Forhøjet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19].
    Lynggaard SE; Nygaard L; Overgaard EK
    Ugeskr Laeger; 2020 Jun; 182(24):. PubMed ID: 32515336
    [No Abstract]   [Full Text] [Related]  

  • 7. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 8. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 9. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 10. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging key laboratory tests for patients with COVID-19.
    Kavsak PA; de Wit K; Worster A
    Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
    Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

  • 14. Temporal changes in computed tomography of COVID-19 pneumonia with perilobular fibrosis.
    Ng FH; Li SK; Lee YC; Ma JKF
    Hong Kong Med J; 2020 Jun; 26(3):250.e1-251.e2. PubMed ID: 32362587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].
    Pan X; Yao Y; Cao C; Huang Y; Wu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Apr; 44(4):359-362. PubMed ID: 32762214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labs scramble to produce new coronavirus diagnostics.
    Cohen J; Kupferschmidt K
    Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
    [No Abstract]   [Full Text] [Related]  

  • 18. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn's Disease Patient.
    Navaneethan U; LehnerNoguera V
    Inflamm Bowel Dis; 2020 Sep; 26(10):e124. PubMed ID: 32578860
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19.
    Ding M; Zhang Q; Li Q; Wu T; Huang YZ
    Respir Med; 2020 Jun; 167():105981. PubMed ID: 32421546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.